journal article·2011-11

Effect of alginate encapsulation on the cellular transcriptome of human islets

Vijayaganapathy Vaithilingam, Nayeem Quayum, Mugdha V. Joglekar, Jan Jensen, Anandwardhan A. Hardikar, Jose Oberholzer, Gilles J. Guillemin, Bernard E. Tuch

Biomaterials· Volume 32· Issue 33
Publisher page

Abstract

Encapsulation of human islets may prevent their immune rejection when transplanted into diabetic recipients. To assist in understanding why clinical outcomes with encapsulated islets were not ideal, we examined the effect of encapsulation on their global gene (mRNA) and selected miRNAs (non-coding (nc)RNA) expression. For functional studies, encapsulated islets were transplanted into peritoneal cavity of diabetic NOD-SCID mice. Genomics analysis and transplantation studies demonstrate that islet origin and isolation centres are a major source of variation in islet quality. In contrast, tissue culture and the encapsulation process had only a minimal effect, and did not affect islet viability. Microarray analysis showed that as few as 29 genes were up-regulated and 2 genes down-regulated (cut-off threshold 0.1) by encapsulation. Ingenuity analysis showed that up-regulated genes were involved mostly in inflammation, especially chemotaxis, and vascularisation. However, protein expression of these factors was not altered by encapsulation, raising doubts about the biosignificance of the gene changes. Encapsulation had no effect on levels of islet miRNAs. In vivo studies indicate differences among the centres in the quality of the islets isolated. We conclude that microencapsulation of human islets with barium alginate has little effect on their transcriptome.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Pancreatic function and diabetes · Epigenetics and DNA Methylation · Genetics and Neurodevelopmental Disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen10.1056/NEJM200007273430401 ↗
2. Islet cell transplantation
3. Alginate-based microcapsules for immunoisolation of pancreatic islets10.1016/j.biomaterials.2006.07.010 ↗
4. An overview on the development of a bio-artificial pancreas as a treatment of insulin-dependent diabetes mellitus10.1002/med.20047 ↗
5. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases10.2337/diacare.29.01.06.dc05-1270 ↗
6. Safety and viability of microencapsulated human islets transplanted into diabetic humans10.2337/dc09-0744 ↗
7. Causes of limited survival of microencapsulated pancreatic islet grafts10.1016/j.jss.2004.02.018 ↗
8. Factors influencing insulin secretion from encapsulated islets10.3727/000000003108747226 ↗
9. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?10.2337/diabetes.48.7.1381 ↗
10. Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets10.1007/s001090050336 ↗
11. Biochemical consequences of alginate encapsulation: a NMR study of insulin-secreting cells10.1016/j.biomaterials.2005.11.042 ↗
12. Automated islet isolation from human pancreas10.2337/diab.38.1.S140 ↗
13. Encapsulation of human islets in novel inhomogeneous alginate-Ca2+/Ba2+ microbeads: in vitro and in vivo function10.1080/10731190802369755 ↗
14. Differentiation of transplanted microencapsulated fetal pancreatic cells10.1097/01.tp.0000264555.46417.7d ↗
15. The miR-30 family microRNAs confer epithelial phenotype to human pancreatic islets10.4161/isl.1.2.9578 ↗
16. Modeling the adhesion of human embryonic stem cells to poly(lactic-co-glycolic acid) surfaces in a 3D environment10.1002/jbm.a.32401 ↗
17. A new mathematical model for relative quantification in real-time RT-PCR10.1093/nar/29.9.e45 ↗
18. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism10.4049/jimmunol.171.12.6929 ↗
19. Chemokines in islet allograft rejection10.1002/dmrr.362 ↗
20. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation10.2337/diabetes.51.1.55 ↗
21. Role of donor-derived monocyte chemoattractant protein-1 in murine islet transplantation10.1681/ASN.2004090743 ↗
22. Quantitative differential expression analysis reveals miR-7 as major islet microRNA10.1016/j.bbrc.2007.12.052 ↗
23. Role of microRNAs in diabetes10.1016/j.bbagrm.2008.06.010 ↗
24. Expression of islet-specific microRNAs during human pancreatic development10.1016/j.gep.2008.10.001 ↗
25. The effects of alginate composition on encapsulated bTC3 cells10.1016/S0142-9612(00)00282-9 ↗
26. The role of the CaCl2–guluronic acid interaction on alginate encapsulated bTC3 cells10.1016/j.biomaterials.2003.09.046 ↗
27. The role of capsule composition and biologic responses in the function of transplanted microencapsulated islets of Langerhans10.1097/01.TP.0000078625.29988.0A ↗
28. Production of purified alginates suitable for use in immunoisolated transplantation10.1007/BF00173321 ↗
29. Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts10.1097/00007890-199610150-00004 ↗
30. Biocompatibility and surface structure of chemically modified immunoisolating alginate-PLL capsules10.1002/jbm.a.10094 ↗
31. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation10.2337/diabetes.54.6.1755 ↗
32. Advances in long-term islet culture: the memphis experience
33. Transdifferentiation of human islet cells in a long-term culture10.1097/00006676-200108000-00006 ↗
34. Improved survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation10.1007/s00125-004-1531-3 ↗
35. Amelioration of streptozotocin-induced diabetes in mice using human islet cells derived from longterm culture in vitro10.1097/00007890-200205150-00015 ↗
36. MicroRNAs: genomics, biogenesis, mechanism, and function10.1016/S0092-8674(04)00045-5 ↗